Paloma Partners’s DexCom DXCM Stock Holding History

Paloma Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,300	Closed	-$296K	–	766
2023 Q2	$296K	Buy	+2,300	New	+$278K	0.01%	556
2022 Q4	–	Sell	-3,500	Closed	-$282K	–	974
2022 Q3	$282K	Sell	3,500 -5,500	-61%	-$466K	0.01%	649
2022 Q2	$670K	Buy	+9,000	New	+$821K	0.02%	539
2021 Q3	–	Sell	-25,200	Closed	-$2.69M	–	1297
2021 Q2	$2.69M	Buy	+25,200	New	+$2.42M	0.05%	343
2021 Q1	–	Sell	-95,200	Closed	-$8.8M	–	2103
2020 Q4	$8.8M	Buy	95,200 +52,000	+120%	+$4.64M	0.23%	83
2020 Q3	$4.45M	Buy	+43,200	New	+$4.51M	0.11%	164
2019 Q2	–	Sell	-12,400	Closed	-$369K	–	1829
2019 Q1	$369K	Buy	+12,400	New	+$436K	0.01%	1211

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Paloma Partners's DXCM Position: Q2 2025 in Review

Paloma Partners sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,164 shares — an estimated $216K sold.

Paloma Partners first reported a position in DXCM in Q1 2015 and held it in 24 quarters. The position peaked at $15.1M in Q2 2020. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

Paloma Partners reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
Paloma Partners sold 3,164 DexCom shares in Q2 2025, an estimated $216K.
Paloma Partners first reported a position in DexCom in Q1 2015 and held it in 24 quarters.
Paloma Partners's DexCom position peaked at $15.1M in Q2 2020.
940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.